BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3533847)

  • 1. [Pemphigus vulgaris--malignant course].
    Steiner A; Diem E
    Hautarzt; 1986 Sep; 37(9):499-502. PubMed ID: 3533847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of pemphigus with plasmapheresis].
    Friedman-Birnbaum R; Schechter Y; Bochner H
    Harefuah; 1989 Sep; 117(5-6):135-7. PubMed ID: 2485756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
    Euler HH; Löffler H; Christophers E
    Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris.
    Turner MS; Sutton D; Sauder DN
    J Am Acad Dermatol; 2000 Dec; 43(6):1058-64. PubMed ID: 11100023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
    Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
    Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange as a crisis option in severe pemphigus vulgaris.
    Ranugha PS; Kumari R; Kartha LB; Parameswaran S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2012; 78(4):508-10. PubMed ID: 22772632
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in the treatment of pemphigus].
    Blaszczyk M; Chorzelski T; Daszynski J; Jabłońska S; Beutner EH
    Z Hautkr; 1985 Aug; 60(15):1175-82. PubMed ID: 4049988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trials with therapeutic plasmapheresis in pemphigus vulgaris].
    Neppert J; Meissner K; Voigt H; Meigel W
    Z Hautkr; 1980 Jun; 55(12):783-9. PubMed ID: 7415360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclosporin A in the treatment of pemphigus foliaceus and pemphigus erythematosus].
    Balda BR; Rosenzweig D
    Hautarzt; 1986 Aug; 37(8):454-7. PubMed ID: 3531092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apheresis therapy for the treatment of pemphigus and auto-immune blistering disease].
    Mayuzumi N; Ikeda S; Ogawa H
    Nihon Rinsho; 2004 May; 62 Suppl 5():612-6. PubMed ID: 15197995
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continuous plasma filtration. Experiences in the treatment of pemphigus vulgaris].
    Vennemann F; Schedel A; Lorenzen M
    Z Hautkr; 1984 Aug; 59(16):1075-9. PubMed ID: 6485455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method.
    Ogata K; Yasuda K; Matsushita M; Kodama H
    J Dermatol; 1999 Apr; 26(4):236-9. PubMed ID: 10343469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pemphigus vulgaris with plasmapheresis].
    Woscoff A; Di Lonardo AM; Remondino G; Carballo G; Laviano N; Ledesma L; Jaimovich L
    Medicina (B Aires); 1988; 48(4):395-400. PubMed ID: 3255031
    [No Abstract]   [Full Text] [Related]  

  • 14. Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
    Fine JD; Appell ML; Green LK; Sams WM
    Arch Dermatol; 1988 Feb; 124(2):236-9. PubMed ID: 3277542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillamine-induced pemphigus foliaceus-like dermatosis. A case with unusual features, successfully treated by plasmapheresis.
    Bahmer FA; Bambauer R; Stenger D
    Arch Dermatol; 1985 May; 121(5):665-8. PubMed ID: 3158288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus vulgaris affecting 19 nails.
    Patsatsi A; Sotiriou E; Devliotou-Panagiotidou D; Sotiriadis D
    Clin Exp Dermatol; 2009 Mar; 34(2):202-5. PubMed ID: 18795937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged treatment with rituximab in patients with refractory pemphigus vulgaris.
    Barrera MV; Mendiola MV; Bosch RJ; Herrera E
    J Dermatolog Treat; 2007; 18(5):312-4. PubMed ID: 17852643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
    Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
    Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of a paraneoplastic pemphigus in a teenager using plasmapheresis, corticosteroids and tumour resection.
    Jing L; Shan Z; Yongchu H; Xixue C; Xuejun Z
    Clin Exp Dermatol; 2011 Oct; 36(7):752-4. PubMed ID: 21933232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.